Delivery Order SPE2DB22D3501-SPE2DB25FWL91
Award Date 7/17/25
Potential Completion Date 8/7/25
Potential Value $9.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the delivery of XOLAIR 300 MG/2 ML AUTOINJECT 2ML. The $9,564.96 fixed-price delivery order has an ultimate completion date of August 6, 2025. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a wide range of pharmaceutical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a firm fixed price of $3,188.32 and an ultimate completion date of August 1, 2025. The contract is for the provision of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a pharmaceutical product, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The $10,128.48 Firm Fixed Price contract has a completion date of June 4, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,782.48 firm fixed-price delivery order is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, with a performance period ending on July 24, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,188.32 delivery order contract is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a pharmaceutical product. The contract is a firm fixed price award with an ultimate completion date of August 7, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,881.36 delivery order contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a medical product, with a performance period through July 18, 2025. The contract is a firm fixed-price delivery order, not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,393.14 Firm Fixed Price delivery order is for the supply of XOLAIR 300 MG/2 ML SYRINGE 2ML, with a performance period extending through June 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of XOLAIR 150 MG/ML SYRINGEML. The $3,376.16 firm fixed-price delivery order has a completion date of June 4, 2025 and is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a global pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,188.32 firm fixed price delivery order is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, with a completion date of August 7, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGE-ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,440.70 firm fixed price delivery order was competitively awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 7, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...